Scrip
GSK takes up antibiotic option under Anacor alliance
30 July 2010
Peter Mansell
Please Login to read the full article.
30 July 2010
Peter Mansell
GlaxoSmithKline has exercised its option under a strategic alliance with US company Anacor Pharmaceuticals to take up an exclusive licence for the development and commercialisation of GSK2251052 (GSK '052), a novel systemic antibiotic.
The decision brings Anacor an option exercise fee of $15...
Please Login to read the full article.
RELATED CONTENT
COMMENT
Other Informa Comment
FEATURES
- Face-to-Face: Trophos - The French firm that hooked Actelion
- Interview: Croatia's state insurer changes its role to raise efficiency
EVENTS
01 January 1970
London, UK
01 January 1970
San Diego, US
01 January 1970
Providence, Rhode Island, and San Francisco, California
JOB OF THE WEEK
Promote your vacancy here
